翻訳と辞書 |
GeoVax
GeoVax is a biotechnology company established primarily to develop an effective and safe vaccine against HIV-1. Ultimately the company is to create vaccines for many serious human diseases for which none currently exist. GeoVax is currently conducting multiple site Phase 2 Human clinical trials for HIV/AIDS preventative vaccine products following successful completion of multiple Phase 1 human clinical trials.〔GeoVax Labs, Inc. (Human Trials. ) Company information page.〕 In 2010 GeoVax began enrolling patients in a Phase 1 therapeutic clinical trial for individuals already infected with HIV.〔GeoVax Labs, Inc. ("GeoVax Labs Granted Allowance by FDA To Start Phase 1 Clinical Trial for HIV/AIDS Therapeutic Vaccine: ) Company Will Begin Non-Blinded Study in HIV Infected Individuals Who Started Drug Treatment During Their First Year of Infection." Media release. March 30, 2010.〕 The long-term therapeutic goal is to develop a vaccine-based mechanism to treat infected individuals that either prevents or significantly slows progression to symptomatic HIV, including AIDS, by stimulating an infected individual's immune system to resist the progression of infection. The study is being completed at the AIDS Research Consortium of Atlanta.〔Shafer, Matt. ("ARCA Seeks Volunteers for Historic HIV Vaccine Trial." ) ''GA Voice.'' June 11, 2010.〕〔GeoVax Labs, Inc. ("New Progress for HIV/AIDS Therapeutic Vaccine As First Trial Moves Forward" ) ''Newswise.'' June 11, 2010.〕〔GeoVax Labs, Inc. ("ARCA Launches First Therapeutic Trial with GeoVax Vaccine: ) Study to Enroll HIV-Infected Individuals Who Started Drug Treatment During Their First Year of Infection." Media release. May 27, 2010.〕 ==Corporate history== Formed in 2001 in Atlanta, Georgia, the approach used in HIV-1 vaccine development was originally based on preclinical work done by Dr. Harriet Robinson〔(Harriet Robinson PhD. ) Emory University, Emory Center for AIDS Research.〕〔 (Harriet L Robinson ) Labome.org.〕 from 1992 to 2002. In 2002 laboratory space, equipment and personnel were acquired and work on an HIV-1 vaccine development plan began, and in May 2006 human clinical trials of the drug began.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「GeoVax」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|